Expanding Access to Pompe Disease Therapies in Developing Regions Advancing Pompe Disease Therapies: Expanding Access and Innovation Understanding Pompe Disease Pompe disease is a rare, progressive genetic disorder caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). This enzyme deficiency leads to glycogen accumulation in muscle
The Next Generation of Myeloma Therapies: BMS vs. Janssen The competition in the Multiple Myeloma treatment market is intensifying as two pharmaceutical giants, Bristol Myers Squibb (BMS) and Janssen, vie for dominance. Both companies have made significant advancements in developing therapies for Multiple Myeloma, a cancer affecting plasma cells
Redefining Chemotherapy: Novel Approaches at AACR 2025 AACR 2025: Shaping the Future of Cancer Research What is AACR? The American Association for Cancer Research (AACR), established in 1907, is a worldwide leader in cancer research. It serves as a platform for scientists, clinicians, and healthcare professionals to come together, exchange i